HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever
HistoSonics, a trailblazer in non-invasive histotripsy technology, has successfully concluded an oversubscribed $102 million Series D financing round. The round was spearheaded by Alpha Wave ... Read More